About

Michael Tauber is Senior Director of Pharmaceutical Development at Acorda Therapeutics. Since 2002, he has worked in various areas of pharmaceutical development, including early- and late-stage development, pre-formulation and formulation for solid oral development, formulation and scale-up of spray-dried engineered particles for inhalation delivery and management of chemistry, manufacturing and controls (CMC) related activities supporting the development and commercialisation of Inbrija (levodopa inhalation powder).
Additionally, Mr Tauber has served as the solid-state chemistry technical lead on numerous projects over the years and has established solid-state labs, as well as instructed many peers on this topic. He also managed all aspects of the extractables and leachables programme for Inbrija through NDA/MAA approval. Mr Tauber holds a BS in Chemistry from UMass Boston and an MS in Chemistry from Northeastern University.